< Back to all Breaking News
ALZN
7/28/2021 15:07pm
Alzamend Neuro reports FDA 'study may proceed' letter for Phase 1 study 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
